Status:
UNKNOWN
SweMaMi DMI, Microbiome
Lead Sponsor:
Karolinska Institutet
Conditions:
Type 1 Diabetes
Eligibility:
FEMALE
18+ years
Brief Summary
Dysbiosis is associated with an increased risk of preeclampsia during pregnancy. The microbiome differs between those with and without type 1 diabetes and the cause of type 1 diabetes has been associa...
Detailed Description
Prospective cohort. All women with type 1 diabetes that are planning a pregnancy and being cared for at the diabetic ward at Södersjukhuset will be asked to participate, n= 55. All pregnancies compli...
Eligibility Criteria
Inclusion
- Pregnant Women with type 1 diabetes
- Included as a patient at women's clinic Soderhospital in Stockholm
- Acceptant to sample her microbiome during pregnancy
Exclusion
- Women without type 1 diabetes
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04346524
Start Date
April 1 2020
End Date
December 30 2022
Last Update
November 23 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Eva Wiberg-Itzel
Danderyd, Sverige, Sweden, 18239
2
Eva Wiberg-Itzel
Stockholm, Sweden, 18239